Loading organizations...
Cancer molecular information service for precision diagnosis and treatment.
ACT Genomics has raised $12.5M across 1 funding round.
ACT Genomics has raised $12.5M in total across 1 funding round.
ACT Genomics has raised $12.5M in total across 1 funding round.
ACT Genomics's investors include CDIB Capital, Hotung Venture Group, Eminent II Venture Capital, Hua Nan Venture Capital, President International Development Corporation, UMC Capital.
ACT Genomics has raised $12.5M across 1 funding round. Most recently, it raised $12.5M Series B in May 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 6, 2016 | $12.5M Series B | CDIB Capital, Hotung Venture Group | Eminent II Venture Capital, Hua Nan Venture Capital, President International Development Corporation, UMC Capital |